developing ways to control the spatial and temporal amplification of ROS generation to effectively treat severe pathological conditions characterised by a dysfunction in ROS homeostasis.
These conditions include
- inflammatory and autoimmune diseases,
- cancer and
- myeloablation
Photos of PI’s of NeutroCure:
Upper row: A. Mokhir, M. Hoffmann, M. Herrmann, M. Hultquist,
Lower row: H. Griffiths, A. Hidalgo Alonso, R. Bilyy, G. Kroemer